4 patents currently held
16 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
The next term ends in Sep 2039. from the record
Of the 16 now held by other companies, 16 name Napp Pharmaceutical Group Limited as their current owner. Each row says so.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
Sep 2039
Next term end
2
Patent families
When these terms end
Held patents by the year their term ends
notable patents
all others
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Only 2 of the currently held patents qualify as notable.
Notable
Ends no later than Sep 2039 · Low confidence
Also notable
Ends no later than Sep 2040 · Medium confidence
Compositions and Methods for the Treatment of Viral Infections
US 11,833,213
Granted 2023. Computed term ends 2039. A terminal disclaimer is on file and its reference is not resolved, so no cap is applied and the date may move earlier, never later.
Compositions and Methods for the Treatment of Viral Infections
US 11,510,992
A family of 5 related applications built on the 2022 grant. Protection runs to 2040. A terminal disclaimer is on file and its reference is not resolved, so no cap is applied and the date may move earlier, never later.
Formerly held, still cited
Notable
Ends Mar 2032 · High confidence
Cited by 8 later US patents, top 10% of utility patents granted in 2023 in our data. Protection runs to 2032. A terminal disclaimer caps this term to an earlier patent's.
now held by Napp Pharmaceutical Group Limited
Also notable
Ends Mar 2032 · High confidence
Cited by 24 later US patents, top 25% of utility patents granted in 2017 in our data, and renewed at every maintenance window due so far. Protection runs to 2032.
now held by Napp Pharmaceutical Group Limited
Also notable
Ends Jul 2038 · High confidence
Cited by 12 later US patents, top 25% of utility patents granted in 2021 in our data. Protection runs to 2038.
now held by Napp Pharmaceutical Group Limited
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Jun 5, 2027The maintenance fee for Compositions and Methods for the Treatment of Viral Infections (US 11,833,213) comes due Jun 5, 2027. Unpaid by Dec 6, 2027, it lapses early.
Recent changes
- Sep 22Assignment recorded on 1 record: Borchardt, Allen and 8 others to Cidara Therapeutics, Inc. Recorded Sep 22, 2026, executed Dec 3, 2024. Conveyance as recorded: Assignment of Assignor's Interest. A recorded assignment is a filed document, not a statement of current ownership. Reel 76514, frame 685.
- Sep 22Assignment recorded on 1 record: Borchardt, Allen and 11 others to Cidara Therapeutics, Inc. Recorded Sep 22, 2026, executed Nov 15, 2024. Conveyance as recorded: Assignment of Assignor's Interest. A recorded assignment is a filed document, not a statement of current ownership. Reel 76520, frame 265.
What they patent
Grouped by real patent family, largest first, labeled by the earliest filing in each. No technology classification is inferred from titles.
| Compositions and Methods for the Treatment of Viral Infections (2021) | 2 in force | to May 2041 |
| Compositions and Methods for the Treatment of Viral Infections (2021) | 2 in force | to Jan 2040 |
Patents held now
Soonest term end first.
Showing 1 to 4 of 4
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,833,213 | Compositions and Methods for the Treatment of Viral Infections In force · Low confidence | In force | Low confidence | |
| US 12,569,565 | Compositions and Methods for the Treatment of Viral Infections In force · Medium confidence | In force | Medium confidence | |
| US 11,510,992 | Compositions and Methods for the Treatment of Viral Infections In force · Medium confidence | In force | Medium confidence | |
| US 12,427,200 | Compositions and Methods for the Treatment of Viral Infections In force · High confidence | In force | High confidence |
Also on record, not counted in the 4: 16 patents in force now held by others · 9 applications pending · 22 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
4 terminal disclaimers are on file with no resolved reference. No cap is applied and none is guessed